 |
|
|
| |
Greater sequence diversity during early hepatitis B virus decline on vebicorvir plus entecavir is associated with a lower level of virus rebound following switch to entecavir monotherapy
|
| |
| |
EASL 2022 June 22-26 London
Lewyn Li1, Peter A Revill2, Ran Yan1, Calvin Chan1, Hua Tian1, Julie Ma1, Luisa M Stamm1, Man-Fung Yuen3, Alexander Thompson4, Kathryn M Kitrinos1
1Assembly Biosciences, Inc., South San Francisco, CA, USA; 2Victorian Infectious Diseases Reference Laboratory, Melbourne, Victoria, Australia; 3Department of Medicine, The University of Hong Kong, Hong Kong; 4St. Vincent's Hospital, Melbourne, Fitzroy VIC, Australia
|
| |
|
|
|
|
|
